TCH346

From Wikipedia, the free encyclopedia

This article is orphaned as few or no other articles link to it. Please help introduce links in articles on related topics. (November 2006)

TCH346 is a drug in clinical trials to help treat Amyotrophic Lateral Sclerosis (ALS)

[edit] External Reference

• Neurological Institute of New York Columbia University
• National Center for Biotechnology Information article